HKSE:2666
Genertec Universal Medical Group Company Limited · HKSE · Financial Services · HKD · FY for 2025
Figures on this page computed 2026-11-08 12:41 UTC
Last close
n/aHKD
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
3.7xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
- Computed from the filing for 2025
14.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
15.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
21.2%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
2.60Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
7.6%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
Growth is the furthest below its sector's middle: 0.47 against 0.56 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.64x
Its own average over 10 years, 8.84B.
- Profit1.32x
Its own average over 10 years, 1.67B.
- Free cash flow-3.11x
Its own average over 10 years, -991.7M.
- Debt1.18x
Its own average over 10 years, 42.57B.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at -3.11 times.
It reports in CNY and trades in HKD. Nothing on this page is converted between the two.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 126.4 | 131.7 | 100.0 |
| 2018-12-31 | 158.6 | 155.0 | 100.0 |
| 2019-12-31 | 249.1 | 170.7 | 100.0 |
| 2020-12-31 | 304.3 | 188.9 | 100.0 |
| 2021-12-31 | 353.2 | 223.3 | 118.7 |
| 2022-12-31 | 427.0 | 224.7 | 121.0 |
| 2023-12-31 | 503.9 | 231.7 | 121.4 |
| 2024-12-31 | 504.4 | 234.7 | 117.1 |
| 2025-12-31 | 536.7 | 253.2 | 117.3 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Figures behind the shape
Growth
12.0%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate12.0%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
Five-year EPS growth rate2.4%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
One-year change in net income7.9%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
Returns on capital
14.6%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital14.6%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity11.4%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets2.6%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
34.8%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin34.8%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin87.1%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin15.2%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin21.2%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
3.7xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings3.7x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
- Computed from the filing for 2025
Price to book0.4x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA14.3x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.6x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
2.60safer is higher, placed against 1,436 companies as of 2026-11-07
Debt to equity2.60
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio3.64
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage182.5x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Scoren/a
This measure is not defined for this kind of company, so there is no peer group it belongs in.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
7.6%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield7.6%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
Payout ratio27.9%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio5.0x
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.